Cellectar Biosciences - 48 Year Dividend Yield History | CLRB

Historical dividend payout and yield for Cellectar Biosciences (CLRB) since 1971. The current TTM dividend payout for Cellectar Biosciences (CLRB) as of February 15, 2019 is $0.00. The current dividend yield for Cellectar Biosciences as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.009B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Stryker (SYK) United States $69.625B 25.56
Baxter (BAX) United States $39.075B 24.08
Zimmer Biomet Holdings (ZBH) United States $25.222B 16.18
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Hill-Rom Holdings (HRC) United States $6.974B 21.57
Perrigo (PRGO) Ireland $6.650B 10.09
Phibro Animal Health (PAHC) United States $1.231B 17.70
Meridian Bioscience (VIVO) United States $0.704B 20.97
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
Utah Medical Products (UTMD) United States $0.334B 21.65
United-Guardian (UG) United States $0.091B 18.98